These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1418052)

  • 1. General pharmacology of pergolide in animals. 2nd communication: gastrointestinal, renal and miscellaneous studies.
    Williams PD; Bendele A; Deldar A; McGrath J; Shetler T; Owen N
    Arzneimittelforschung; 1992 Jul; 42(7):891-5. PubMed ID: 1418052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General pharmacology of loracarbef in animals.
    Shetler T; Bendele A; Buening M; Clemens J; Colbert W; Deldar A; Helton D; McGrath J; Shannon H; Turk J
    Arzneimittelforschung; 1993 Jan; 43(1):60-70. PubMed ID: 8447851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacology of pergolide in animals. 1st communication: cardiovascular, respiratory and autonomic nervous system studies.
    Williams P; Colbert W; Turk J; Owen N
    Arzneimittelforschung; 1992 May; 42(5):599-607. PubMed ID: 1530670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General pharmacology of nizatidine in animals.
    Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
    Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical toxicology studies with the new dopamine agonist pergolide. Acute, subchronic, and chronic evaluations.
    Francis PC; Carlson KH; Owen NV; Adams ER
    Arzneimittelforschung; 1994 Mar; 44(3):278-84. PubMed ID: 8192691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics.
    Yamamoto S; Takemori E; Hasegawa Y; Kuroda K; Nakao K; Inukai T; Sakonjyo H; Nishimura T; Nishimori T
    Arzneimittelforschung; 1991 Sep; 41(9):913-23. PubMed ID: 1796919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory activity of pergolide, a dopamine receptor agonist.
    Bendele AM; Spaethe SM; Benslay DN; Bryant HU
    J Pharmacol Exp Ther; 1991 Oct; 259(1):169-75. PubMed ID: 1681083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacology of insulin lispro in animals.
    Helton DR; Zimmermann JL; Heim A; Jones TW; Turk JA; Kallman MJ
    Arzneimittelforschung; 1996 Jan; 46(1):91-7. PubMed ID: 8821525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacology of recombinant human tumor necrosis factor. 1st communication: effects on cardiovascular, gastrointestinal, renal and blood functions.
    Nakatsuji K; Kii Y; Fujitani B; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):218-25. PubMed ID: 2334464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol.
    Terai T; Kusunoki T; Kita Y; Yoshida K; Akahane A; Shiokawa Y; Kohno Y; Horiai H; Mori J; Mine Y; Kohsaka M
    Arzneimittelforschung; 1996 Feb; 46(2):185-91. PubMed ID: 8720311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior.
    Clemens JA; Okimura T; Smalstig EB
    Arzneimittelforschung; 1993 Mar; 43(3):281-6. PubMed ID: 8489554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
    Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.